CT-P47

tocilizumab biosimilar · Celltrion

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CT-P47, covering 2023-02-16 to 2024-10-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis [Phase 3]